publication venue for
- Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms. 2024
- African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.. 30. 2023
- Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors.. 28. 2021
- Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer.. 26. 2019
- Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.. 26. 2019
- UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.. 26. 2019
- Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer.. 25. 2018
- Differentiated thyroid cancer: millions spent with no tangible gain?. 25. 2017
- Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.. 20. 2013
- p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.. 20. 2013
- Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.. 19. 2012
- The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.. 18. 2010
- Methylation profiles of endometrioid and serous endometrial cancers.. 17. 2010
- Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.. 15. 2008
- BRAF(V600E) mutation and the biology of papillary thyroid cancer.. 15. 2008
- Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.. 15. 2008
- RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response.. 12. 2005
- Functional characterization of multiple DICER1 mutations in an adolescent.. 23. 2015
- Regulation of vascular endothelial growth factor in prostate cancer. 2015
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development. 2015
- Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies. 2014
- Current mouse and cell models in prostate cancer research. 2013
- Endocrine complications in long-term survivors of childhood cancers. 2010
- Bone metastases from differentiated thyroid carcinoma. 2008
- Malignant pheochromocytoma: current status and initiatives for future progress. 2004
- Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. 2004
- Clinical studies of apoptosis and proliferation in breast cancer. 1999
- Hooked on zebrafish: insights into development and cancer of endocrine tissues. 2011
- Molecular targets in breast cancer: current status and future directions. 2002